Transplantation of neural stem cells co-transfected with Nurr1 and Brn4 for treatment of Parkinsonian rats

International Journal of Developmental Neuroscience

Volumn 31, Issue 1, 2013, Pages 82-87

  Tan, Xuefeng ^a   Zhang, Lei ^a   Qin, JianBing ^a   Tian, Meiling ^a   Zhu, Huixia ^a   Dong, Chuanming ^a   Zhao, Heyan ^a   Jin, Guohua ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Brn 4; Dopaminergic neuron; Neural stem cells; Nurr1; Parkinson's disease

Indexed keywords

DOPAMINE; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN BRN 4; TRANSCRIPTION FACTOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CORPUS STRIATUM; EMBRYO; ENZYME ACTIVITY; GENETIC TRANSFECTION; IN VIVO STUDY; MALE; MATURITY; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OUTCOME ASSESSMENT; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ADRENERGIC AGENTS; ANIMALS; APOMORPHINE; CELLS, CULTURED; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GREEN FLUORESCENT PROTEINS; MALE; NERVE TISSUE PROTEINS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; OXIDOPAMINE; PARKINSONIAN DISORDERS; POU DOMAIN FACTORS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

PARKINSONIA; RATTUS;

EID: 84870706066     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2012.10.007     Document Type: Article

References (29)

1. Alavian K.N., Scholz C., Simon H.H. Transcriptional regulation of mesencephalic dopaminergic neurons: the full circle of life and death. Movement Disorders 2008, 23:319-328.
2. Allan L.E., Petit G.H., Brundin P. Cell transplatation in Parkinson's disease: problems and perspectives. Current Opinion in Neurobiology 2010, 23:426-432.
3. Andersen B., Rosenfeld M.G. POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocrine Reviews 2001, 22:2-35.
4. Borlongan C.V., Sanberg P.R. Neural transplantation for treatment of Parkinson's disease. Drug Discovery Today 2002, 7:674-682.
5. Castro D.S., Skowronska-Krawczyk D., Armant O., et al. Proneural bHLH and Brn proteins coregulate a neurogenic program through cooperative binding to a conserved DNA motif. Developmental Cell 2006, 11:831-844.
6. Cui Y.F., Hargus G., Xu J.C., et al. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice. Brain 2010, 133:189-204.
7. Deierborg T., Soulet D., Roybon L., et al. Emerging restorative treatments for Parkinson's disease. Progressive Neurobiology 2008, 85:407-432.
8. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
9. Geeta R., Ramnath R.L., Harinaravana S.R., et al. One year survival and significant reversal of motor deficits in Parkinsonian rats transplanted with hESC derived dopaminergic neurons. Biochemistry, Biophysics and Research Communications 2008, 373:258-264.
10. Jensen P., Gramsbergen J.B., Zimmer J., et al. Enhanced proliferation and dopaminergic differentiation of ventral mesencephalic precursor cells by synergistic effect of FGF2 and reduced oxygen tension. Experimental Cell Research 2011, 317:1649-1662.
11. Kapsimali M., Bourrat F., Vernier P. Distribution of the orphan nuclear receptor Nurr1 in medaka (Oryzias latipes): cues to the definition of homologous cell groups in the vertebrate brain. Journal of Computational Neurology 2001, 431:276-292.
12. Kim H.J., Sugimori M., Nakafuku M., et al. Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1. Experimental Neurology 2007, 203:394-405.
13. Ko J.Y., Lee H.S., Park C.H., et al. Conditions for tumor-free and dopamine neuron-enriched grafts after transplanting human ES cell-derived neural precursor cells. Molecular Therapy 2009, 17:1761-1770.
14. Lindvall O., Kokaia Z., Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders: how to make it work. Nature Medicine 2004, 10:s42-s50.
15. Liste I., García-García E., Martínez-Serrano A. The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo. Journal of Neuroscience 2004, 24:10786-10795.
16. Park C.H., Kang J.S., Shin Y.H., et al. Acquisition of in vitro and in vivo functionality of Nurr1-induced dopamine neurons. FASEB Journal 2006, 20:2553-2555.
17. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proceedings of National Academy of Sciences of United States of America 1998, 95:4013-4018.
18. Shi J., Jin G., Tian M., et al. The role of Brn-4 in the regulation of neural stem cell differentiation into neurons. Neuroscience Research 2010, 67:8-17.
19. Shim J.W., Park C.H., Bae Y.C., et al. Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression. Stem Cells 2007, 25:1252-1262.
20. Smits S.M., Ponnio T., Conneely O.M., et al. Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. European Journal of Neuroscience 2003, 18:1731-1738.
21. Sonntag K.C., Simantov R., Isacson O. Stem cells may reshape the prospect of Parkinson's disease therapy. Molecular Brain Research 2005, 134:34-51.
22. Sonntag K.C., Simantov R., Kim K.S., et al. Temporally induced Nurr1 can induce a non-neuronal dpaminergic cell type in embryonic stem cell differentiation. European Journal of Neuroscience 2004, 19:1141-1152.
23. Tan X.F., Jin G.H., Tian M.L., et al. The co-transduction of Nurr1 and Brn4 genes induce the differentiation of neural stem cells into dopaminergic neurons. Cell Biology International 2011, 35:1217-1223.
24. Tan X.F., Qin J.B., Jin G.H., et al. Effects of Brn-4 on the neuronal differentiation of neural stem cells derived from rat midbrain. Cell Biology International 2010, 34:877-882.
25. Trzaska K.A., King C.C., Li K.Y., et al. Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons. Journal of Neurochemistry 2009, 110:1058-1069.
26. Vescovi A.L., Snyder E.Y. Establishment and properties of neural stem cell clones: plasticity in vitro and in vivo. Brain Pathology 1999, 9:569-598.
27. Xiao Q., Castillo S.O., Nikodem V.M. Distribution of messenger RNAs for the orphan nuclear receptors Nurr1 and Nur77 (NGFI-B) in adult rat brain using in situ hybridization. Neuroscience 1996, 75:221-230.
28. Yu Y., Gu S., Huang H., et al. Combination of bFGF, heparin and laminin induce the generation of dopaminergic neurons from rat neural stem cells both in vitro and in vivo. Journal of the Neurological Sciences 2007, 255:81-86.
29. Zhang X., Jin G., Wang L., et al. Brn-4 is upregulated in the deafferented hippocampus and promotes neuronal differentiation of neural progenitors in vitro. Hippocampus 2009, 19:176-186.